* Says co's unit Shanghai Hengrui Pharmaceutical Co Ltd
FDA approval for desflurane for inhalation (product) from U.S.
Food and Drug Administration
* Says it received goods manufacture practice (GMP)
certificate from Health and Youth Care Inspectorate
* TG THERAPEUTICS AND JIANGSU HENGRUI MEDICINE ANNOUNCE
LICENSE AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF NOVEL
BTK INHIBITOR PROGRAM FOR THE TREATMENT OF HEMATOLOGIC